| 1 |
35433850 | The Histone Deacetylase 9 Stroke-Risk Variant Promotes Apoptosis and Inflammation in a Human iPSC-Derived Smooth Muscle Cells Model. | 2022 |
1 |
| 2 |
35565292 | HDAC Inhibition with Valproate Improves Direct Cytotoxicity of Monocytes against Mesothelioma Tumor Cells. | 2022 Apr 26 |
1 |
| 3 |
33031880 | Biocompatible sulfated valproic acid-coupled polysaccharide-based nanocarriers with HDAC inhibitory activity. | 2021 Jan 10 |
1 |
| 4 |
33369712 | Astragaloside IV suppresses post-ischemic natural killer cell infiltration and activation in the brain: involvement of histone deacetylase inhibition. | 2021 Feb |
1 |
| 5 |
34374891 | Effect of valproic acid on miRNAs affecting histone deacetylase in a model of anaplastic thyroid cancer. | 2021 Aug |
2 |
| 6 |
34935488 | HDAC9 in the Injury of Vascular Endothelial Cell Mediated by P38 MAPK Pathway. | 2021 Dec |
2 |
| 7 |
34944565 | Synergistic Anticancer Effect of Glycolysis and Histone Deacetylases Inhibitors in a Glioblastoma Model. | 2021 Nov 23 |
3 |
| 8 |
31898801 | Valproic Acid Decreases Endothelial Colony Forming Cells Differentiation and Induces Endothelial-to-Mesenchymal Transition-like Process. | 2020 Apr |
5 |
| 9 |
32378621 | Effect of epigenetic modulation on cancer sphere. | 2020 |
2 |
| 10 |
32591993 | HDAC Inhibition Induces PD-L1 Expression in a Novel Anaplastic Thyroid Cancer Cell Line. | 2020 Oct |
1 |
| 11 |
30183517 | Palbociclib augments Neratinib killing of tumor cells that is further enhanced by HDAC inhibition. | 2019 |
1 |
| 12 |
31010254 | Influence of the HDAC Inhibitor Valproic Acid on the Growth and Proliferation of Temsirolimus-Resistant Prostate Cancer Cells In Vitro. | 2019 Apr 19 |
5 |
| 13 |
28550492 | microRNA-889 is downregulated by histone deacetylase inhibitors and confers resistance to natural killer cytotoxicity in hepatocellular carcinoma cells. | 2018 Apr |
2 |
| 14 |
28967098 | Epigenetic regulation of melatonin receptors in neuropsychiatric disorders. | 2018 Aug |
2 |
| 15 |
29135083 | Comparison of the anticancer properties of a novel valproic acid prodrug to leading histone deacetylase inhibitors. | 2018 Apr |
5 |
| 16 |
29247141 | Sodium Valproate, a Histone Deacetylase Inhibitor, Is Associated With Reduced Stroke Risk After Previous Ischemic Stroke or Transient Ischemic Attack. | 2018 Jan |
2 |
| 17 |
30050079 | Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cells. | 2018 Jul 26 |
1 |
| 18 |
30107147 | CCR7 preservation via histone deacetylase inhibition promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells. | 2018 Oct 1 |
2 |
| 19 |
28445158 | The HDAC inhibitor valproate induces a bivalent status of the CD20 promoter in CLL patients suggesting distinct epigenetic regulation of CD20 expression in CLL in vivo. | 2017 Jun 6 |
2 |
| 20 |
28542253 | Repurposing the anti-epileptic drug sodium valproate as an adjuvant treatment for diffuse intrinsic pontine glioma. | 2017 |
1 |
| 21 |
26517778 | Histone deactylase gene expression profiles are associated with outcomes in blunt trauma patients. | 2016 Jan |
3 |
| 22 |
26822725 | Quantitative Analysis of Global Proteome and Lysine Acetylome Reveal the Differential Impacts of VPA and SAHA on HL60 Cells. | 2016 Jan 29 |
3 |
| 23 |
26827693 | The safety profile of vorinostat (suberoylanilide hydroxamic acid) in hematologic malignancies: A review of clinical studies. | 2016 Feb |
1 |
| 24 |
26980768 | Enhanced Histone Deacetylase Activity in Malignant Melanoma Provokes RAD51 and FANCD2-Triggered Drug Resistance. | 2016 May 15 |
1 |
| 25 |
27038166 | Antiepileptic drugs with histone deacetylase inhibition activity and prostate cancer risk: a population-based case-control study. | 2016 May |
1 |
| 26 |
27411759 | Anti-fibrotic effects of valproic acid: role of HDAC inhibition and associated mechanisms. | 2016 Aug |
2 |
| 27 |
27470189 | Histone deacetylase inhibitors stimulate the susceptibility of A549 cells to a plasma-activated medium treatment. | 2016 Sep 15 |
2 |
| 28 |
27884140 | Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial. | 2016 Nov 25 |
2 |
| 29 |
25012937 | HDAC inhibition through valproic acid modulates the methylation profiles in human embryonic kidney cells. | 2015 |
3 |
| 30 |
25336333 | Results of phase 2 randomized study of low-dose decitabine with or without valproic acid in patients with myelodysplastic syndrome and acute myelogenous leukemia. | 2015 Feb 15 |
1 |
| 31 |
25656984 | Safety of valproic acid in patients with chronic obstructive pulmonary disease: a population-based cohort study. | 2015 Mar |
3 |
| 32 |
25950486 | Neuronal developmental gene and miRNA signatures induced by histone deacetylase inhibitors in human embryonic stem cells. | 2015 May 7 |
4 |
| 33 |
25960665 | Randomized Phase II trial of paclitaxel plus valproic acid vs paclitaxel alone as second-line therapy for patients with advanced gastric cancer. | 2015 |
2 |
| 34 |
26108793 | Nucleolar Translocation of Histone Deacetylase 2 Is Involved in Regulation of Transcriptional Silencing in the Cat Germinal Vesicle. | 2015 Aug |
2 |
| 35 |
26185616 | Cellular prostatic acid phosphatase (cPAcP) serves as a useful biomarker of histone deacetylase (HDAC) inhibitors in prostate cancer cell growth suppression. | 2015 |
1 |
| 36 |
26318673 | Histone deacetylase inhibitors relieve morphine resistance in neuropathic pain after peripheral nerve injury. | 2015 Aug |
2 |
| 37 |
26482599 | Antiepileptic drug use improves overall survival in breast cancer patients with brain metastases in the setting of whole brain radiotherapy. | 2015 Nov |
4 |
| 38 |
26735433 | Induction of autophagy by valproic acid enhanced lymphoma cell chemosensitivity through HDAC-independent and IP3-mediated PRKAA activation. | 2015 |
5 |
| 39 |
24511897 | Suppression of adipogenesis by valproic acid through repression of USF1-activated fatty acid synthesis in adipocytes. | 2014 May 1 |
4 |
| 40 |
24890032 | Is sodium valproate, an HDAC inhibitor, associated with reduced risk of stroke and myocardial infarction? A nested case-control study. | 2014 Jul |
1 |
| 41 |
25108044 | The histone deacetylase (HDAC) inhibitor valproic acid reduces ethanol consumption and ethanol-conditioned place preference in rats. | 2014 Oct 2 |
3 |
| 42 |
25446377 | Synergism of arsenic trioxide and MG132 in Raji cells attained by targeting BNIP3, autophagy, and mitochondria with low doses of valproic acid and vincristine. | 2014 Dec |
4 |
| 43 |
23010695 | Enantioselective apoptosis induction in histiocytic lymphoma cells and acute promyelocytic leukemia cells. | 2013 Feb |
4 |
| 44 |
23097134 | Sodium valproate potentiates staurosporine-induced apoptosis in neuroblastoma cells via Akt/survivin independently of HDAC inhibition. | 2013 Apr |
2 |
| 45 |
23292124 | Synergistic effects of histone deacetylase inhibitor in combination with mTOR inhibitor in the treatment of prostate carcinoma. | 2013 Feb |
2 |
| 46 |
23448466 | Potential roles of HDAC inhibitors in mitigating ischemia-induced brain damage and facilitating endogenous regeneration and recovery. | 2013 |
1 |
| 47 |
23647222 | The mood stabilizer valproate activates human FGF1 gene promoter through inhibiting HDAC and GSK-3 activities. | 2013 Jul |
1 |
| 48 |
23836985 | Inhibition of leukemic cells by valproic acid, an HDAC inhibitor, in xenograft tumors. | 2013 |
1 |
| 49 |
24006305 | HDAC inhibition suppresses bladder cancer cell adhesion to collagen under flow conditions. | 2013 Nov 1 |
4 |
| 50 |
22473339 | Low dosed interferon alpha augments the anti-tumor potential of histone deacetylase inhibition on prostate cancer cell growth and invasion. | 2012 Dec 1 |
4 |